US WorldMeds is committed to the future

In Development

US WorldMeds is committed to improving the lives of our patients, both in the products that we market and in the therapies that are currently under development. This commitment can be seen in our pipeline, where we are diligently working to bring new therapies and new indications to patients across multiple therapeutic areas.

Phases 1 2 3 R 4
Apomorphine Infusion
Idiopathic Parkinson's disease
Melphalan
Multiple myeloma
RimabotulinumtoxinB
Sialorrhea
R = Registration

Ongoing Clinical Trials

Clinical trials are the cornerstone of furthering our mission to improving the lives of patients. US WorldMeds is committed to sponsoring safe and effective trials that help to better the lives of patients.

Drug
Apomorphine Infusion
Condition
Idiopathic Parkinson’s Disease
Phase
3
Study Title
Infusion of Apomorphine: Long-term Safety Study (INFUS-ON)
Link

Grant and Research Support

Thank you for your interest in US WorldMeds. As part of our goal to positively change lives through improved healthcare, we are strongly committed to supporting independent medical education activities and Investigator-Initiated Research (IIR). Please see the guidelines below for submitting medical education grant requests and IIR proposals. We look forward to reviewing your application.

Support by US WorldMeds of independent medical education activities is limited to only those that fall within the company's specific areas of therapeutic focus:

  • Treatment of motor fluctuations in Parkinson's disease
  • Treatment of non-motor symptoms of Parkinson's disease
  • Botulinum toxin in the use of cervical dystonia, movement disorders, and other areas of unmet need
  • Increasing awareness of opioid withdrawal syndrome (OWS) and available treatment options
  • Educating on differences between opioid dependence, opioid tolerance, and Opioid Use Disorder (OUD)
  • Funding for medical fellowships/scholarships

The completed medical education grant request application should be sent electronically to our Medical Affairs Department at grants@usworldmeds.com.
A full description of all necessary documents is outlined in the Guidelines for Medical Education Grant Requests.

Please check back periodically for any updates to current areas of therapeutic focus.

US WorldMeds recognizes that IIRs enable research that has the potential to improve the lives of patients with challenging conditions and unmet medical needs. The program is offered to all institutional and community-based scientists and clinicians who are interested in conducting their own research, and support is awarded based on the scope of the proposal and its scientific merit.

In general, IIRs are smaller in scale than Phase IV Research and are "proof of concept" or "exploratory" in nature. US WorldMeds may provide funding and other forms of support, such as clinical trial materials, to support studies initiated and sponsored by outside researchers.

For consideration of support, a complete IIR proposal should be sent electronically to our Medical Affairs department at grants@usworldmeds.com. Furthermore, in order to protect the ideas of those we work with, please fill out the highlighted fields in this 2-way Confidential Disclosure Agreement (CDA) prior to submitting a complete proposal.

A complete proposal includes the following:

  • The IIR Request Form filled out in its entirety
  • Full Study Protocol
  • 2-way CDA
  • A curriculum vitae for each interested investigator and any co- and/or sub-Investigators (if applicable)
  • Proposed budget
  • Other supporting documentation

For an initial review of a proposed study concept only to gauge the interest of US WorldMeds for support, please fill out and send back the IIR Request Form and CDA to grants@usworldmeds.com.

Lofexidine Areas of Interest:

  • Treatment of opioid withdrawal symptoms with lofexidine in patients without OUD (e.g., patients with chronic pain) to support abrupt opioid discontinuation or tapering off from short- or long-acting opioids
  • Treatment of opioid withdrawal symptoms with lofexidine after acute naloxone administration
  • Improving the rate of successful conversion to depot naltrexone using lofexidine for withdrawal

The complete IIR proposal should be sent electronically to our Medical Affairs Department at grants@usworldmeds.com. The IIR Request Form filled out in its entirety, along with submission of all other supporting documentation, constitutes a complete proposal.

Only fully-completed medical education grant applications and IIR proposals will be reviewed. Completing the application does not guarantee approval, and approval does not guarantee an award of support in the entire amount being requested.

The contact person at the requesting organization will be notified within three months of receipt of the application with the approval or denial status. Therefore, funding requests must be submitted no later than three (3) months prior to the date of the event, as applicable, to ensure sufficient time for internal review.

If US WorldMeds is able to provide funding/support for the medical education activity or research trial, a Letter of Agreement (provided by US WorldMeds) must be signed by US WorldMeds and the Medical Education Provider or Independent Research Organization.

Any activity for which support is awarded is required to be compliant with and adhere to federal and state guidelines and regulations, including, but not limited to, the FDA Final Guidance on Industry-Supported Scientific and Educational Activities, the Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support, the American Medical Association (AMA) Ethical Guidelines for Gifts to Physicians from Industry, and the Pharmaceutical Research and Manufacturers of America (PhRMA) Code on Interactions with Healthcare Professionals, where applicable.

All grant and research support is awarded at US WorldMeds' sole discretion. Approval of grant funding or research support is never related to or conditioned upon past, promised, or potential future prescriptions or purchases of US WorldMeds' products. US WorldMeds does not offer or provide medical education grants or research support to encourage or to reward the prescription, purchase, ordering, or recommending of US WorldMeds products.

If you have any questions regarding independent medical education grants or IIRs, please contact our Medical Affairs Department at grants@usworldmeds.com.